Deep Track Capital, LP Astria Therapeutics, Inc. Transaction History

Deep Track Capital, LP

  • $2.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$6.89 - $9.86 $4.54 Million - $6.5 Million
-659,542 Reduced 38.86%
1,037,873 $7.74 Million
Q2 2023

Aug 14, 2023
SELL
$8.33 - $13.72 $992,236 - $1.63 Million
-119,116 Reduced 6.56%
1,697,415 $14.1 Million
Q4 2022

Feb 14, 2023
BUY
$7.44 - $14.89 $13.5 Million - $27 Million
1,816,531 New
1,816,531 $27 Million

Others Institutions Holding ATXS

# of Institutions
107
Shares Held
48.6M
Call Options Held
48K
Put Options Held
9.3K
View Full List

About Astria Therapeutics, Inc.

ATXS Quotes by TradingView
  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $150M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email